"But consider this; the vast majority of medicines associated with new drug patents are not new. Nearly 8 out of 10 are for existing ones, like insulin or aspirin.

My organisation, a team of lawyers and scientists, recently conducted an investigation into the 12 best-selling drugs in [US]America. We found that on average, there are 125 patents filed on each medicine. Often for things we've known how to do for decades ..."

#PritiKrishtel, 2020

https://www.ted.com/talks/priti_krishtel_why_are_drug_prices_so_high_investigating_the_outdated_us_patent_system?rss=

#patents #DrugPatents

Priti Krishtel: Why are drug prices so high? Investigating the outdated US patent system

TED

(1/?)

@CatherineOrganic1
> Patent law in medicine means good medicines are dumped for the new and unproven

Indeed. Also there's a powerful incentive to fund research into novel chemicals or equipment that might get patents. But little or no incentive to research generic plant medicines, or non-medicinal treatments, which probably won't. Even where there's good reason to believe they might be more effective and cheaper to provide.

#patents #DrugPatents

The second one is that public debate, including on health policy, has been kept between a very narrow set of goalposts. Fixing Pharmac is the most ambitious thing the panelists can come up with. No discussion of abolishing drug patents - as we have with software patents - so our health system can manufacture the medicines we need at cost.

#Pharmac #DrugPatents

Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition
The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.
#globalnews #Health #USNews #Drugpatents #drugmakers
https://globalnews.ca/news/10460967/us-drug-patents-challenged-ozempic/
Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition

The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.

Global News
Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition
The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.
#globalnews #Health #USNews #Drugpatents #drugmakers
https://globalnews.ca/news/10460967/us-drug-patents-challenged-ozempic/
Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition

The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.

Global News

"What I discovered is that... [pharmaceutical corporations] don't, by and large, invent medicines. They behave like hedge funds. They buy the rights to produce medicines that have been made by others - with public money, or at small biotech companies - and then they squeeze the most they possibly can out of those drugs Whatever the consequences are to society... [or] how unaffordable they are."

#NickDearden, 2024

https://www.currentaffairs.org/2023/11/how-big-pharma-makes-a-killing-from-letting-people-die

#podcasts #CurrentAffairs #BigPharma #DrugPatents

How Big Pharma Makes a Killing From Letting People Die ❧ Current Affairs

<p>Journalist Nick Dearden on the basics of “pharmanomics.” </p>

Current Affairs

Targeting costly meds, #Biden admin asserts authority to seize certain drug patents https://www.politico.com/news/2023/12/06/biden-admin-authority-seize-certain-drug-patents-00130452

"The decision could give the #president another tool to use in his effort to lower #DrugPrices"

#USpol #HealthCare #JoeBiden #Pharma #Democrats #DrugPatents #PresidentBiden

Targeting costly meds, Biden admin asserts authority to seize certain drug patents

The decision could give the president another tool to use in his effort to lower drug prices.

POLITICO

After Decades of Pressure, US Drugmaker J&J Gives Up Patent on Life-Saving TB Drug

This move can lead to the entry of many manufacturers of bedaquiline, thereby reducing the exorbitant price which many governments currently find difficult to afford for all of their patients, say activists.

https://thewire.in/health/after-decades-of-pressure-us-drugmaker-jj-gives-up-patent-on-life-saving-tb-drug

#tuberculosis #JohnsonAndJohnson #bedaquiline #sirturo #DrugResistantTB #DRTB #LMICs #DrugPatents #drugs #medicine #health #healthcare #india

After Decades of Pressure, US Drugmaker J&J Gives Up Patent on Life-Saving TB Drug

This move can lead to the entry of many manufacturers of bedaquiline, thereby reducing the exorbitant price which many governments currently find difficult to afford for all of their patients, say activists.

The Wire
Barely Contained Rage: An Open Letter to Johnson & Johnson

YouTube